XML 135 R116.htm IDEA: XBRL DOCUMENT v3.10.0.1

Contingencies and commitments (PCSK9 Antibody Patent Litigation) (Details) - patent	Nov. 30, 2018	Mar. 18, 2016	Dec. 15, 2014
Sanofi/Regeneron Patent Litigation [Member]
Other Commitments [Line Items]
Number of patents allegedly infringed			7
Length of trial		5 days
Patent Disputes in the International Region [Member]
Other Commitments [Line Items]
Length of trial	3 days

X

- Definition

Litigation Settlement, Length of Trial

+ References

No definition available.

+ Details

Name:	amgn_LitigationSettlementLengthofTrial
Namespace Prefix:	amgn_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Number of entity's patents that another entity has allegedly infringed.

+ References

No definition available.

+ Details

Name:	us-gaap_GainContingencyPatentsAllegedlyInfringedUponNumber
Namespace Prefix:	us-gaap_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_OtherCommitmentsLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Details

Name:	srt_LitigationCaseAxis=amgn_SanofiRegeneronPatentLitigationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_LitigationCaseAxis=amgn_PatentDisputesintheInternationalRegionMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: